Scott Xiao is a seasoned entrepreneur and expert in digital therapeutics, currently serving as a Fellow at Health Evolution since May 2024. As Co-Founder and CEO of Luminopia since October 2015, Scott developed the first VR-based digital therapeutic to achieve FDA approval, enabling patients to use their favorite TV shows as treatment for amblyopia. Additionally, Scott holds the position of Co-Founder and Chief Scientific Officer at the Harvard Project for Asian and International Relations (HPAIR) since September 2017. Previous roles include Co-Founder at Odin, Head Mentor for the Canadian Chemistry Olympiad, and Researcher at the Broad Institute. Scott's academic background includes a degree from Harvard University.
This person is not in the org chart
This person is not in any teams